Abstract
The present study was aimed at assessing the anti-depressant activity of the alcoholic extracts of the leaves of Alternanthera sessilis and Clerodendrum infortunatum. The activity was studied on Swiss Albino mice using the Tail Suspension Test and the Forced Swim Test, at doses of 100mg/kg b.w. and 20 mg/kg b.w. with Diazepam as the standard drug. Both the extracts, at higher dose, exhibited significant reduction in the duration of immobility. The alcoholic extract of Clerodendrum infortunatum was the most active extract in both the animal models, at a dose of 200 mg/kg b.w. Thus this study verifies the claims of antidepressant activity of these plants in the tradional medicine.
Keywords: Alternanthera sessilis, anti-depressant, clerodendrum infortunatum.
The Natural Products Journal
Title:Antidepressant Like Effects of Alternanthera sessilis and Clerodendrum infortunatum Leaves Extract in Immobility Models
Volume: 4 Issue: 1
Author(s): Rajiv Gupta and Hemant K. Singh
Affiliation:
Keywords: Alternanthera sessilis, anti-depressant, clerodendrum infortunatum.
Abstract: The present study was aimed at assessing the anti-depressant activity of the alcoholic extracts of the leaves of Alternanthera sessilis and Clerodendrum infortunatum. The activity was studied on Swiss Albino mice using the Tail Suspension Test and the Forced Swim Test, at doses of 100mg/kg b.w. and 20 mg/kg b.w. with Diazepam as the standard drug. Both the extracts, at higher dose, exhibited significant reduction in the duration of immobility. The alcoholic extract of Clerodendrum infortunatum was the most active extract in both the animal models, at a dose of 200 mg/kg b.w. Thus this study verifies the claims of antidepressant activity of these plants in the tradional medicine.
Export Options
About this article
Cite this article as:
Gupta Rajiv and K. Singh Hemant, Antidepressant Like Effects of Alternanthera sessilis and Clerodendrum infortunatum Leaves Extract in Immobility Models, The Natural Products Journal 2014; 4 (1) . https://dx.doi.org/10.2174/2210315504666140515004826
DOI https://dx.doi.org/10.2174/2210315504666140515004826 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Association between TNF-alpha, IL-1 alpha and IL-10 with Alzheimer's Disease
Current Alzheimer Research MiR-22-3p Regulates Amyloid β Deposit in Mice Model of Alzheimer's Disease by Targeting Mitogen-activated Protein Kinase 14
Current Neurovascular Research microRNAs and Molecular Pathogenesis of Microcephaly
Current Molecular Pharmacology Commentary (Brilliant Blue G: What a Little More Colour Can Be)
CNS & Neurological Disorders - Drug Targets Progress in the Preparation and Testing of Glycine Transporter Type-1 (GlyT1) Inhibitors
Current Topics in Medicinal Chemistry Cyclooxygenase and Neuroinflammation in Parkinsons Disease Neurodegeneration
Current Neuropharmacology Bipolar Disorder: The Role of the Kynurenine and Melatonergic Pathways
Current Pharmaceutical Design On the Limitations of Biological Knowledge
Current Genomics The Role of Adenosine in Alzheimers Disease
Current Neuropharmacology Editorial (Thematic Issue: An Overwiew on the Chemistry and Biochemistry of Triterpenoids)
Mini-Reviews in Organic Chemistry MiR-29 Targets PUMA to Suppress Oxygen and Glucose Deprivation/Reperfusion (OGD/R)-induced Cell Death in Hippocampal Neurons
Current Neurovascular Research Drug Repurposing Approaches: Existing Leads for Novel Threats and Drug Targets
Current Protein & Peptide Science Editorial [Hot Topic: New Avenues of Research on Multiple Sclerosis from the Perspective of Chronic Cerebrospinal Venous Insufficiency Paradigm (Guest Editor: Marian Simka)]
Reviews on Recent Clinical Trials A Quantitative Structure-Activity Relationship Study on Some Imidazoles and 2-Aminopyridines Acting as Nitric Oxide Synthase (NOS) Inhibitors
Letters in Drug Design & Discovery Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Characterisation of Mitochondrial DNA Deletions by Long-PCR in Central Nervous System Regions of Young, Middle- and Old-aged Rats
Current Aging Science Role of Grina/Nmdara1 in the Central Nervous System Diseases
Current Neuropharmacology Nose to Brain Delivery of Galantamine Loaded Nanoparticles: In-vivo Pharmacodynamic and Biochemical Study in Mice
Current Drug Delivery Quantitative Structure-Activity Relationship (QSAR) Analysis to Predict Drug-Drug Interactions of ABC Transporter ABCG2
Mini-Reviews in Medicinal Chemistry Medicinal Chemistry of Antimigraine Drugs
Current Medicinal Chemistry